Genome-wide CRISPR screening identifies tyrosylprotein sulfotransferase-2 as a target for augmenting anti-PD1 efficacy.

Autor: Oh, Yumi1 (AUTHOR), Kim, Sujeong2 (AUTHOR), Kim, Yunjae2 (AUTHOR), Kim, Hyun2 (AUTHOR), Jang, Dongjun3 (AUTHOR), Shin, Seungjae3 (AUTHOR), Lee, Soo-Jin3 (AUTHOR), Kim, Jiwon3 (AUTHOR), Lee, Sang Eun3 (AUTHOR), Oh, Jaeik4 (AUTHOR), Yang, Yoojin3 (AUTHOR), Kim, Dohee3 (AUTHOR), Jung, Hae Rim1 (AUTHOR), Kim, Sangjin2 (AUTHOR), Kim, Jihui2 (AUTHOR), Min, Kyungchan2 (AUTHOR), Cho, Beomki2 (AUTHOR), Seo, Hoseok5,6 (AUTHOR), Han, Dohyun5,7 (AUTHOR), Park, Hansoo2,8 (AUTHOR) hspark27@gist.ac.kr
Zdroj: Molecular Cancer. 8/2/2024, Vol. 23 Issue 1, p1-19. 19p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje